[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3633 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 3633

    To amend the Public Health Service Act to provide for a public 
awareness campaign with respect to human papillomavirus, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 24, 2023

   Ms. Castor of Florida (for herself, Ms. Letlow, and Ms. Schrier) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
    To amend the Public Health Service Act to provide for a public 
awareness campaign with respect to human papillomavirus, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Promoting Resources to Expand 
Vaccination, Education and New Treatments for HPV Cancers Act of 2023'' 
or the ``PREVENT HPV Cancers Act of 2023''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) The human papillomavirus (referred to in this Act as 
        ``HPV'') causes six different types of cancer (anal, cervical, 
        oropharynx, penile, vaginal, and vulvar).
            (2) Approximately 37,300 cases of cancer are caused by HPV 
        each year impacting both women and men.
            (3) About 90 percent of cervical and anal cancers are 
        thought to be caused by HPV.
            (4) Black and Hispanic women are more likely to get HPV-
        associated cervical cancer than women of other races and 
        ethnicities due to disparities in access to cancer screening 
        and early detection.
            (5) New cases of cervical cancer decreased among women in 
        young age groups, likely due to HPV vaccination, but in recent 
        years, new cases of cervical cancer rates among women in older 
        age groups have plateaued or, in the case of women ages 30-34, 
        increased.
            (6) Cervical cancer screening has declined and there has 
        been an increase in cervical cancer diagnosed at distant 
        stages, which are more difficult to treat and more likely to 
        recur, leading to greater morbidity and mortality.
            (7) Approximately 60 to 70 percent of oropharynx cancer is 
        tied to HPV.
            (8) Most HPV infections that can lead to cancer can be 
        prevented by vaccines.
            (9) HPV vaccines can also help prevent recurrent 
        respiratory papillomatosis, anal and genital warts.
            (10) Vaccination for HPV is approved for men and women.
            (11) The vaccines are most effective if administered when 
        an individual is between the ages of 9 and 17.
            (12) Approximately 60 percent of adolescents have completed 
        the HPV vaccine series.
            (13) Adolescents living in rural areas continue to be less 
        likely to have initiated and completed the HPV vaccine series 
        than those living in urban areas.
            (14) Health providers' recommendation of the vaccine is 
        critical to getting adolescents vaccinated.

SEC. 3. HPV VACCINE PUBLIC AWARENESS CAMPAIGN.

    (a) In General.--Section 317 of the Public Health Service Act (42 
U.S.C. 247b) is amended by adding at the end the following new 
subsection:
    ``(o) HPV Vaccine Public Awareness Campaign.--
            ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and Prevention, 
        shall carry out a national campaign to--
                    ``(A) increase awareness of the importance of HPV 
                vaccination;
                    ``(B) combat misinformation about HPV vaccination; 
                and
                    ``(C) increase HPV vaccination rates and completion 
                of the vaccine series, especially among males.
            ``(2) Consultation.--In carrying out the national campaign 
        required by paragraph (1), the Secretary shall consult with the 
        National Academy of Medicine, including health care providers 
        and public health associations, nonprofit organizations 
        (including those that represent communities most impacted by 
        HPV-associated cancers and communities with low vaccination 
        rates), State and local public health departments, elementary 
        and secondary education organizations (including student and 
        parent organizations), and institutions of higher education, to 
        solicit advice on evidence-based information for policy 
        development and program development, implementation, and 
        evaluation.
            ``(3) Requirements.--The national campaign required by 
        paragraph (1) shall--
                    ``(A) include the use of evidence-based media and 
                public engagement;
                    ``(B) be carried out through competitive grants or 
                cooperative agreements awarded to 1 or more private, 
                nonprofit entities with a history developing and 
                implementing similar campaigns;
                    ``(C) include the development of culturally and 
                linguistically competent resources that shall be 
                tailored for--
                            ``(i) communities with high rates of--
                                    ``(I) unvaccinated individuals, 
                                including males;
                                    ``(II) individuals with unique 
                                health care needs (such as lesbian, 
                                gay, bisexual, transgender, and queer 
                                individuals);
                                    ``(III) individuals with high rates 
                                of cervical cancer and other HPV-
                                associated cancers (such as Black and 
                                Hispanic women); and
                                    ``(IV) populations impacted by the 
                                increase in oropharynx cancers;
                            ``(ii) rural communities; and
                            ``(iii) such other communities as the 
                        Secretary determines appropriate;
                    ``(D) include the dissemination of HPV vaccination 
                information and communication resources to health care 
                providers and health care facilities (including primary 
                care providers, community health centers, dentists, 
                obstetricians, and gynecologists), and such providers 
                and such facilities for pediatric care, State and local 
                public health departments, elementary and secondary 
                schools, and colleges and universities;
                    ``(E) be complementary to, and coordinated with, 
                any other Federal efforts with respect to HPV 
                vaccination;
                    ``(F) include message testing to identify 
                culturally competent and effective messages for 
                behavioral change; and
                    ``(G) include the award of grants or cooperative 
                agreements to State, local, and Tribal public health 
                departments--
                            ``(i) to engage with communities specified 
                        in subparagraph (C), local education agencies, 
                        health care providers, community organizations, 
                        or other groups the Secretary determines are 
                        appropriate to develop and deliver effective 
                        strategies to increase HPV vaccination rates; 
                        and
                            ``(ii) to disseminate culturally and 
                        linguistically competent resources on the 
                        National Breast and Cervical Cancer Early 
                        Detection Program and where an individual can 
                        access the screenings locally.
            ``(4) Options for dissemination of information.--The 
        national campaign required by paragraph (1) may--
                    ``(A) include the use of--
                            ``(i) social media, television, radio, 
                        print, the internet, and other media;
                            ``(ii) in-person or virtual public 
                        communications; and
                            ``(iii) recognized, trusted figures;
                    ``(B) be targeted to specific groups and 
                communities specified in paragraph (3)(C); and
                    ``(C) include the dissemination of information 
                highlighting each of the following:
                            ``(i) Recommended age range to get the HPV 
                        vaccine.
                            ``(ii) The benefits of getting vaccinated 
                        against HPV, including the potential to not 
                        acquire HPV-associated cancers.
                            ``(iii) HPV vaccine safety and the systems 
                        in place to monitor such safety.
            ``(5) Authorization of appropriations.--There is authorized 
        to be appropriated to carry out this subsection $5,000,000 for 
        each of fiscal years 2024 through 2028.''.
    (b) Report to Congress.--Not later than 2025, the Secretary of 
Health and Human Services shall submit to the Committee on Energy and 
Commerce of the House of Representatives and the Committee on Health, 
Education, Labor and Pensions of the Senate a report--
            (1) that contains a qualitative assessment of the campaign 
        under subsection (o) of section 317 of the Public Health 
        Service Act (42 U.S.C. 247b), as added by subsection (a), and 
        the activities conducted under such campaign; and
            (2) on, with respect to the impact on cancer associated 
        with human papillomavirus, the activities conducted under such 
        subsection (o).

SEC. 4. BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM.

    (a) In General.--Section 1510(a) of the Public Health Service Act 
(42 U.S.C. 300n-5(a)) is amended by striking ``and $275,000,000 for 
fiscal year 2012'' and inserting ``$275,000,000 for fiscal year 2012, 
and $300,000,000 for each fiscal years 2024 through 2028''.
    (b) Coordinating Committee.--Section 1501(d) of the Public Health 
Service Act (42 U.S.C. 300k(d)) is amended--
            (1) in the subsection heading, by striking ``2020'' and 
        inserting ``2030''; and
            (2) by striking ``2020'' and inserting ``2025''.
                                 <all>